Cargando…

Disease spectrum of abnormal serum free light chain ratio and its diagnostic significance

OBJECTIVE: To analyze the spectrum of abnormal serum free light chain ratio (sFLC κ/λ ratio), and to redefine the range of sFLC κ/λ ratio, so as to achieve hierarchical diagnosis of diseases with abnormal sFLC κ/λ ratio, resulting in the increased sensitivity and specificity in the diagnosis of mono...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Bin, Tang, Yi, Zhou, Jianfeng, Zhang, Peiling, Li, Huijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669888/ https://www.ncbi.nlm.nih.gov/pubmed/29137262 http://dx.doi.org/10.18632/oncotarget.19391

Ejemplares similares

The Clinical Significance of Serum Free Light Chains in Bladder Cancer
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2023)

Association between abnormal serum free light chains ratio and known prognostic factors in lymphoma; a nephrology viewpoint
por: Moghimi, Minoosh, et al.
Publicado: (2016)

Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
por: Sarris, Katerina, et al.
Publicado: (2013)

P900: INVOLVED/UNINVOLVED SERUM FREE LIGHT CHAIN RATIO IS A STRONGER PREDICTOR OF DIAGNOSTIC/RISK FACTORS IN LIGHT CHAIN COMPARED TO HEAVY CHAIN MONOCLONAL GAMMOPATHIES
por: Thorir Oskarsson, Jon, et al.
Publicado: (2023)

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials
por: Lopez-Anglada, Lucia, et al.
Publicado: (2018)

A case of light chain deposition disease involving the kidney with a normal serum free kappa/lambda light chain ratio
por: Zhang, Suojian, et al.
Publicado: (2022)

Light chain myeloma and detection of free light chains in serum and urine of dogs and cats
por: Harris, Robert Adam, et al.
Publicado: (2021)

Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
por: Zach, David, et al.
Publicado: (2021)

Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myeloma
por: Willrich, Maria Alice V., et al.
Publicado: (2022)

Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2019)

Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies
por: Lee, Won Sok, et al.
Publicado: (2018)

Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma
por: Teng, M, et al.
Publicado: (2014)

Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees
por: Glenn, Martha J., et al.
Publicado: (2019)

Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio
por: Singh, Gurmukh
Publicado: (2017)

Using Two Detection Methods to Observe the Changes and Significance of Free Light Chain in Serum and Urine in Patients with Renal Insufficiency
por: Xu, Lengnan, et al.
Publicado: (2022)

Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy
por: Kleeberg, L, et al.
Publicado: (2009)

Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2016)

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy
por: Hutchison, Colin A, et al.
Publicado: (2012)

Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma
por: Schieferdecker, Aneta, et al.
Publicado: (2020)

Serum Free Light Chain Only Myeloma with Cytoplasmic IgM
por: Ebana, Hideaki, et al.
Publicado: (2014)

Low serum free light chain is associated with risk of COPD exacerbation
por: Tanimura, Kazuya, et al.
Publicado: (2020)

Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients
por: Sprangers, Ben, et al.
Publicado: (2020)

Serum free light chains and multiple myeloma: Is it time to extend their application?
por: Markovic, Uros, et al.
Publicado: (2020)

Comparison of serum and urine free light chain analysis in clinical diagnosis
por: Cho, Jooyoung, et al.
Publicado: (2022)

Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS
por: Presslauer, Stefan, et al.
Publicado: (2014)

Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
por: Klein, Eva-Maria, et al.
Publicado: (2021)

A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
por: Sandfeld-Paulsen, Birgitte, et al.
Publicado: (2022)

Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains
por: Liu, Fengping, et al.
Publicado: (2021)

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study
por: Simone, Marta, et al.
Publicado: (2023)

Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients
por: García de Veas Silva, José Luis, et al.
Publicado: (2016)

Elevated serum polyclonal immunoglobulin free light chains in patients with severe asthma
por: Basile, Umberto, et al.
Publicado: (2023)

Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma
por: Suehara, Yasuhito, et al.
Publicado: (2017)

Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
por: Duell, Frida, et al.
Publicado: (2020)

Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
por: De Novellis, Danilo, et al.
Publicado: (2022)

Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease
por: Grados, Aurélie, et al.
Publicado: (2013)

Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
por: Yadav, Punit, et al.
Publicado: (2018)

Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies
por: Kumar, Shaji, et al.
Publicado: (2019)

Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2020)

Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements
por: Natali, Patrizia, et al.
Publicado: (2022)

Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio
por: Szabo, Agoston Gyula, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sntjaudsag1sq75l1gsbh3m7dr